INNVInnovAge Holding Corp.

$9.10+97% 1Y

Price

+97%1Y

End-of-day closes, not the intraday tick.

More going right than wrong

Quality mixed, nothing alarming, price roughly fair, growing in the filings, the market undecided.

RyuScore 21 of 100: see how it is built
What they do

InnovAge is the leading healthcare delivery platform by number of participants focused on providing all-inclusive, capitated care to high-cost, seniors, many of whom are dual-eligible. Our programs are designed to address two of the most pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of our participant-centered care delivery approach is to improve the quality of care our participants receive, while keeping them in their homes for as long as safely possible and reducing over-utilization of high-cost care settings such as hospitals and nursing homes.

In the company’s own words · 10-K filed Sep 9, 2025 · SEC EDGAR

P/En/a
Market value$1.40B
1 year+97%
5 years-35%

Charts

As reported to the SEC, without any scoring.

InnovAge Holding Corp. (INNV) reported revenue of $262M in Q4 2026 (quarter ended Jun 30, 2026), up 18% from the same quarter a year earlier. That came with a gross margin of 24% and net income of $8.3M (3.2% of revenue). For the full year FY2026, revenue was $990M (+16% year on year) and net income −$2.5M. Its largest product in Q3 2026 (quarter ended Mar 31, 2026) was Capitation at $252M, 100% of the disclosed total, well ahead of Other Service at 0.2%. The next results filing is expected around Dec 8, 2026, a quarter after the last one.

What the company said

The company's own words from its current reports to the SEC, newest first

  1. Sep 24, 2026On September 22, 2026, InnovAge Holding Corp. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with the selling shareholder named in Schedule II thereto (the “Selling Shareholder”) and Barclays Capital Inc., Goldman Sachs & Co. LLC and Wells Fargo Securities, LLC, as …Other event · Form 8-K
  2. May 12, 2026On May 11, 2026, the Board of Directors (the “Board”) of InnovAge Holding Corp. (the “Company”) appointed Ms. Jennifer Browne as President and Chief Operating Officer of the Company, effective as of June 8, 2026 (the “Effective Date”)Director or officer change · Form 8-K
  3. Jan 29, 2026On January 28, 2026, the Board of Directors (the “Board”) of InnovAge Holding Corp. (the “Company”) appointed Pavithra Mahesh and Sean Traynor as members of the Board, effective immediately.Director or officer change · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.

Business segments

Q3 2026 · $251.9M

The company’s own SEC segment disclosure.

  • Capitation$251.5M100%
  • Other Service$441.0K0%

Why these answers

Each answer with the checks it was read from. Open one for the numbers.

15/19 checks · as of Oct 9, 2026

Conflicts between checks are named, never averaged, and thin data says so.